Surgery for cure of small cell bronchial carcinoma (SCLC) at early stages and postoperative combined modality treatment.
Karrer
K
K
Inst. for Epidemiology of Neoplasms, Vienna-A, Austria.
Denck
H
H
Karnicka-Mlodkowska
H
H
Drings
P
P
Erzen
J
J
Salzer
G M
GM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D003131:Combined Modality Therapy; D018849:Controlled Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging; D016019:Survival Analysis; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D008130:Lomustine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate